ALMS vs REGN: Which Stock is Better?
Side-by-side comparison of Alumis Inc and Regeneron Pharmaceuticals Inc in 2026
ALMS
Alumis Inc
$26.34
REGN
Regeneron Pharmaceuticals Inc
$774.66
Key Metrics Comparison
| Metric | ALMS | REGN | Winner |
|---|---|---|---|
| Market Cap | $3.50B | $81.62B | REGN |
| P/E Ratio | N/A | 18.62 | REGN |
| EPS (TTM) | $N/A | $41.46 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 100.0% | 44.6% | ALMS |
Analyze ALMS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALMS or REGN a better investment?
Comparing ALMS and REGN: Alumis Inc has a market cap of $3.50B while Regeneron Pharmaceuticals Inc has $81.62B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALMS and REGN?
ALMS (Alumis Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALMS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALMS or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for ALMS.
Which company is more profitable: ALMS or REGN?
Alumis Inc (ALMS) has higher gross margins at 100.0% compared to 44.6% for REGN.
Which is the larger company: ALMS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $81.62B compared to $3.50B for ALMS.
Should I buy ALMS or REGN in 2026?
Both ALMS and REGN have investment merit. ALMS trades at $26.34 while REGN trades at $774.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALMS and REGN stock?
Key differences: Market Cap ($3.50B vs $81.62B), P/E Ratio (N/A vs 18.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (100.0% vs 44.6%).